NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that revenues for the first quarter increased more than 2 percent year over year on a GAAP basis, or more than 4 percent excluding currency effects.

The Carlsbad, Calif.-based firm said that for the three months ended March 31, GAAP revenues totaled $962.5 million, up from $939.1 million, and surpassing the consensus Wall Street estimate of $958.6 million.

On a non-GAAP basis the company reported $962.9 million in revenues, up 3 percent from $939.0 million a year ago.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.